Martin Maiers, MS, is the Vice President of Research at Be The Match BioTherapies. He and his team develop software and analytical methods used to predict factors that can impact outcomes for patients who receive an allogeneic cell therapy. Maiers has worked with many allogeneic cell therapy developers in both the early stages of therapy development and as they move through clinical trials.